GIST
Clinical trials for GIST explained in plain language.
Never miss a new study
Get alerted when new GIST trials appear
Sign up with your email to follow new studies for GIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for rare stomach cancer in Late-Stage trial
Disease control OngoingThis study tests a new drug called ripretinib against the current standard sunitinib for people with advanced gastrointestinal stromal tumor (GIST) that has a specific genetic change and has stopped responding to the first treatment, imatinib. About 54 adults will be randomly ass…
Matched conditions: GIST
Phase: PHASE3 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 26, 2026 05:24 UTC
-
New hope for GIST patients: drug combo targets resistant tumors
Disease control OngoingThis study tests a combination of two drugs, bezuclastinib and sunitinib, in 40 adults with advanced gastrointestinal stromal tumors (GIST) that continued to grow despite sunitinib treatment alone. The goal is to see if the combination can slow cancer progression and to identify …
Matched conditions: GIST
Phase: PHASE2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated May 22, 2026 13:54 UTC